Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coagulation changes in individuals with sickle cell trait.

American journal of hematology·2002

Same author

Ascorbate levels in red blood cells and urine in patients with sickle cell anemia.

American journal of hematology·2000

Same author

Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection.

Clinical and diagnostic laboratory immunology·2000

Same author

Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.

Clinical and diagnostic laboratory immunology·1999

Same author

Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease.

The Journal of laboratory and clinical medicine·1999

Same author

Increased expression of regeneration and tolerance factor in individuals with human immunodeficiency virus infection.

Clinical and diagnostic laboratory immunology·1999

Search research articles

Related Experiment Video

Updated: May 6, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Bullets, lead poisoning and thyrotoxicosis

C R Cagin, M Diloy-Puray, M P Westerman

Annals of Internal Medicine

|October 1, 1978

Summary

This summary is machine-generated.

A retained bullet led to lead poisoning in a patient with thyrotoxicosis. Increased bone mobilization during hypermetabolism released lead, causing poisoning in individuals with high body lead burdens.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 6, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

Area of Science:

Toxicology
Endocrinology
Bone Metabolism

Background:

Lead poisoning is a serious condition that can result from exposure to lead.
Thyrotoxicosis is a condition characterized by excessive thyroid hormone production, leading to a hypermetabolic state.
Bone is a significant reservoir for lead in the body.

Observation:

A patient with a retained bullet presented with symptoms of lead poisoning.
The patient also had concurrent thyrotoxicosis, a condition causing increased metabolic activity.
Laboratory data indicated lead mobilization from bone.

Findings:

The hypermetabolic state associated with thyrotoxicosis likely increased the mobility of lead stored in the patient's bone.
This mobilization led to elevated lead levels in the blood and subsequent lead poisoning.
The case supports the hypothesis that metabolic changes can trigger lead release from bone.

Implications:

This case highlights the potential for lead poisoning in individuals with existing lead burdens during periods of significant metabolic alteration.
It underscores the importance of considering lead exposure in patients with unexplained symptoms during hypermetabolic conditions.
Further research into the dynamics of lead mobilization from bone during metabolic stress is warranted.